ArticleRespiratory medicine case reports2026
Quantitative CT monitoring of extracorporeal photopheresis response in chronic lung allograft dysfunction: A retrospective case series.
Article in Respiratory medicine case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To explore the feasibility and preliminary behavior of the Computer-Aided Lung Informatics for Pathology Evaluation and Rating (CALIPER) tool in detecting radiologic differences in lung parenchyma of lung transplant recipients undergoing extracorporeal photopheresis (ECP) for chronic lung allograft dysfunction (CLAD). Methods: We performed a retrospective case review on a series of adult lung transplant recipients at Mayo Clinic who had a baseline CT following transplant, underwent ECP for CLAD, and had follow-up CT imaging. Our primary outcome was temporal change in lung parenchymal morphology exemplars assessed by CALIPER. Secondary outcomes included changes in distribution of vascular-related structures, calculated lung volumes, and spirometric indices. Data was analyzed using a linear mixed effects model. Findings: Of 91 eligible recipients with CLAD, 15 were treated with ECP. Following ECP we observed an increase in normal lung tissue (p = 0.038) and a decrease in interstitial lung abnormalities (p = 0.003). There was no significant difference in hyperlucent areas, distribution of pulmonary vascular-related structures, or calculated lung volumes. There was a slight increase in FVC (p < 0.001) after initiation of ECP, but no significant change in FEV Conclusions: Initiation of ECP was associated with favorable parenchymal changes as calculated by CALIPER in this sample of patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.